LEANNE LONG: Open Payments
NPI 1508550005 · PLYMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 13 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $64 · 2025 $489
Food & beverage: $462Education: $27
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $331 |
| ABBVIE INC. | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Alkermes, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: COBENFY, VRAYLAR, INVEGA SUSTENNA, REXULTI, ARISTADA, CAPLYTA.
Industry payments across MA — which companies pay providers there.
